Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Robert P Foglia

Robert P Foglia

University of Texas Southwestern Medical Center, USA

Title: Pediatric complex, complicated appendicitis: Is non-operative management appropriate?

Biography

Biography: Robert P Foglia

Abstract

Background: Complex complicated appendicitis (CCA), perforation with large abscess formation, can have a high operative morbidity. An alternative, non-operative management (NOM), with antibiotics and abscess drainage by interventional radiology can have a significant failure rate. Our aim was to review NOM and outcomes at one hospital.

Study Design: We reviewed 100 consecutive cases of NOM for CCA at Children’s Health Dallas. Data included demographics, symptom length, drainage, complications, and length of stay (LOS). Primary endpoint was discharge without operation. Secondary endpoints were complications or unplanned readmission. Results are expressed as median (interquartile range).

Results: Patient age was 9 (5.2-12.2) years, and symptom duration 6 (5-7) days. All patients received parenteral antibiotics. Eighty-three children had abscess drainage and 17 had abscesses which could not be drained due to their location. LOS was 5.6 (4.1-7.9) days. Antibiotic duration was 13 (11-17.3) days. No child required appendectomy, nor had a major complication at the time discharge. Seventeen children were readmitted, 14 for gastrointestinal or infectious issues, 10 (3-14) days after discharge. They were treated with antibiotics and, in three, drain placement. One patient had appendectomy for unresolved appendicitis. Three children had recurrent appendicitis 43 (37-63.5) days after discharge, and underwent appendectomy.

Conclusions: NOM was successful in all children during initial hospitalization, and offers an excellent therapeutic risk:benefit ratio in CCA. Readmission and recurrence rates are lower than previously reported.